Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	ARID1B SUPT20H MAGED1 NR3C1 ARID1A PDLIM1 BCLAF1 DDX5	5.24e-05	562	48	8	GO:0003712
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TARDBP ARID1B SUPT20H MAGED1 NR3C1 ARID1A PDLIM1 BCLAF1 BTRC DDX5	3.64e-04	1160	48	10	GO:0030674
GeneOntologyMolecularFunction	mRNA 3'-UTR binding	TARDBP ILF3 PUM1 RBMS2 DDX5	5.13e-04	276	48	5	GO:0003730
GeneOntologyMolecularFunction	glucosidase activity	MGAM KL	5.82e-04	15	48	2	GO:0015926
GeneOntologyMolecularFunction	transcription coactivator activity	ARID1B MAGED1 NR3C1 ARID1A PDLIM1	7.81e-04	303	48	5	GO:0003713
GeneOntologyBiologicalProcess	transcription initiation-coupled chromatin remodeling	ARID1B NR3C1 ARID1A EGR1	1.57e-05	65	48	4	GO:0045815
GeneOntologyBiologicalProcess	positive regulation of gene expression, epigenetic	ARID1B NR3C1 ARID1A EGR1	1.88e-05	68	48	4	GO:0141137
GeneOntologyBiologicalProcess	positive regulation of double-strand break repair	ARID1B ING3 ARID1A SMCHD1	7.04e-05	95	48	4	GO:2000781
GeneOntologyBiologicalProcess	regulation of hormone biosynthetic process	GH2 NR3C1 EGR1	8.00e-05	36	48	3	GO:0046885
GeneOntologyBiologicalProcess	regulation of steroid biosynthetic process	GH2 APOB NR3C1 EGR1	1.08e-04	106	48	4	GO:0050810
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	ARID1B NR3C1 ARID1A EGR1 BCLAF1	1.95e-04	231	48	5	GO:0006352
GeneOntologyBiologicalProcess	regulation of DNA repair	ARID1B SUPT20H ING3 ARID1A SMCHD1	2.07e-04	234	48	5	GO:0006282
GeneOntologyBiologicalProcess	regulation of lipid biosynthetic process	GH2 APOB NR3C1 EGR1 SIRT3	2.61e-04	246	48	5	GO:0046890
GeneOntologyBiologicalProcess	circadian rhythm	TARDBP MAGED1 EGR1 BTRC DDX5	2.71e-04	248	48	5	GO:0007623
GeneOntologyBiologicalProcess	regulation of steroid metabolic process	GH2 APOB NR3C1 EGR1	2.73e-04	135	48	4	GO:0019218
GeneOntologyBiologicalProcess	nuclear receptor-mediated steroid hormone signaling pathway	GH2 NR3C1 ARID1A DDX5	2.81e-04	136	48	4	GO:0030518
GeneOntologyBiologicalProcess	regulation of hormone metabolic process	GH2 NR3C1 EGR1	3.34e-04	58	48	3	GO:0032350
GeneOntologyBiologicalProcess	positive regulation of DNA repair	ARID1B ING3 ARID1A SMCHD1	3.40e-04	143	48	4	GO:0045739
GeneOntologyBiologicalProcess	regulation of double-strand break repair	ARID1B ING3 ARID1A SMCHD1	3.68e-04	146	48	4	GO:2000779
GeneOntologyBiologicalProcess	regulation of lipid metabolic process	GH2 APOB PDE3B NR3C1 EGR1 SIRT3	3.84e-04	415	48	6	GO:0019216
GeneOntologyBiologicalProcess	steroid hormone receptor signaling pathway	GH2 NR3C1 ARID1A DDX5	4.62e-04	155	48	4	GO:0043401
GeneOntologyBiologicalProcess	motor neuron migration	CELSR3 CELSR2	5.46e-04	15	48	2	GO:0097475
GeneOntologyCellularComponent	bBAF complex	ARID1B ARID1A	2.20e-04	10	47	2	GO:0140092
GeneOntologyCellularComponent	chromatin	FANCD2 TARDBP ARID1B HOXC8 SUPT20H MAGED1 ING3 NR3C1 ARID1A EGR1 ARNT2	3.50e-04	1480	47	11	GO:0000785
GeneOntologyCellularComponent	npBAF complex	ARID1B ARID1A	4.43e-04	14	47	2	GO:0071564
GeneOntologyCellularComponent	brahma complex	ARID1B ARID1A	4.43e-04	14	47	2	GO:0035060
GeneOntologyCellularComponent	nBAF complex	ARID1B ARID1A	5.82e-04	16	47	2	GO:0071565
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	ARID1B ING3 ARID1A	1.31e-03	96	47	3	GO:0070603
Domain	GAIN_dom_N	ADGRL1 CELSR3 CELSR2	2.28e-06	11	46	3	IPR032471
Domain	GAIN	ADGRL1 CELSR3 CELSR2	2.28e-06	11	46	3	PF16489
Domain	BAF250_C	ARID1B ARID1A	5.93e-06	2	46	2	IPR033388
Domain	BAF250_C	ARID1B ARID1A	5.93e-06	2	46	2	PF12031
Domain	BAF250/Osa	ARID1B ARID1A	5.93e-06	2	46	2	IPR021906
Domain	HormR	ADGRL1 CELSR3 CELSR2	3.10e-05	25	46	3	SM00008
Domain	HRM	ADGRL1 CELSR3 CELSR2	4.39e-05	28	46	3	PF02793
Domain	GPS	ADGRL1 CELSR3 CELSR2	7.93e-05	34	46	3	SM00303
Domain	GPS	ADGRL1 CELSR3 CELSR2	8.66e-05	35	46	3	PF01825
Domain	GPS	ADGRL1 CELSR3 CELSR2	9.43e-05	36	46	3	PS50221
Domain	GPS	ADGRL1 CELSR3 CELSR2	1.02e-04	37	46	3	IPR000203
Domain	G_PROTEIN_RECEP_F2_1	ADGRL1 CELSR3 CELSR2	1.30e-04	40	46	3	PS00649
Domain	GPCR_2_extracellular_dom	ADGRL1 CELSR3 CELSR2	1.30e-04	40	46	3	IPR001879
Domain	G_PROTEIN_RECEP_F2_3	ADGRL1 CELSR3 CELSR2	1.30e-04	40	46	3	PS50227
Domain	G_PROTEIN_RECEP_F2_2	ADGRL1 CELSR3 CELSR2	2.53e-04	50	46	3	PS00650
Domain	7tm_2	ADGRL1 CELSR3 CELSR2	2.53e-04	50	46	3	PF00002
Domain	GPCR_2_secretin-like	ADGRL1 CELSR3 CELSR2	4.34e-04	60	46	3	IPR000832
Domain	GPCR_2-like	ADGRL1 CELSR3 CELSR2	4.34e-04	60	46	3	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRL1 CELSR3 CELSR2	4.55e-04	61	46	3	PS50261
Domain	-	ARID1B ARID1A	6.11e-04	15	46	2	1.10.150.60
Domain	BRIGHT	ARID1B ARID1A	6.11e-04	15	46	2	SM00501
Domain	ARID_dom	ARID1B ARID1A	6.11e-04	15	46	2	IPR001606
Domain	ARID	ARID1B ARID1A	6.11e-04	15	46	2	PS51011
Domain	ARID	ARID1B ARID1A	6.11e-04	15	46	2	PF01388
Domain	Cadherin_CS	PCDHB6 CELSR3 CELSR2	2.45e-03	109	46	3	IPR020894
Domain	EGF_LAM_2	CELSR3 CELSR2	2.47e-03	30	46	2	PS50027
Domain	EGF_LAM_1	CELSR3 CELSR2	2.47e-03	30	46	2	PS01248
Domain	CADHERIN_1	PCDHB6 CELSR3 CELSR2	2.71e-03	113	46	3	PS00232
Domain	Cadherin	PCDHB6 CELSR3 CELSR2	2.71e-03	113	46	3	PF00028
Domain	CADHERIN_2	PCDHB6 CELSR3 CELSR2	2.78e-03	114	46	3	PS50268
Domain	-	PCDHB6 CELSR3 CELSR2	2.78e-03	114	46	3	2.60.40.60
Domain	CA	PCDHB6 CELSR3 CELSR2	2.85e-03	115	46	3	SM00112
Domain	Cadherin-like	PCDHB6 CELSR3 CELSR2	2.92e-03	116	46	3	IPR015919
Domain	Cadherin	PCDHB6 CELSR3 CELSR2	3.06e-03	118	46	3	IPR002126
Domain	GPCR_2_secretin-like_CS	ADGRL1 CELSR3	3.17e-03	34	46	2	IPR017983
Domain	Laminin_EGF	CELSR3 CELSR2	3.35e-03	35	46	2	PF00053
Domain	EGF_Lam	CELSR3 CELSR2	3.35e-03	35	46	2	SM00180
Domain	EGF	MEP1B CELSR3 CELSR2	3.68e-03	126	46	3	PF00008
Domain	LAM_G_DOMAIN	CELSR3 CELSR2	3.94e-03	38	46	2	PS50025
Domain	Laminin_EGF	CELSR3 CELSR2	3.94e-03	38	46	2	IPR002049
Domain	Laminin_G_2	CELSR3 CELSR2	4.36e-03	40	46	2	PF02210
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	MAGED1 ARNT2	6.67e-05	5	37	2	MM16637
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4	MAGED1 NR3C1 ARNT2	9.42e-05	34	37	3	M46422
Pathway	WP_MRNA_PROCESSING	TARDBP ILF3 PUM1 VIRMA BCLAF1 RBMS2 DDX5	1.47e-04	451	37	7	MM15946
Pathway	WP_CIRCADIAN_RHYTHM_GENES	MAGED1 EGR1 BTRC DDX5 ARNT2	1.69e-04	201	37	5	M39605
Pathway	BIOCARTA_HSWI_SNF_PATHWAY	NR3C1 ARID1A	2.98e-04	10	37	2	MM1532
Pathway	REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION	HOXC8 ILF3	2.98e-04	10	37	2	M48016
Pathway	REACTOME_REGULATION_OF_CDH11_EXPRESSION_AND_FUNCTION	HOXC8 ILF3	4.35e-04	12	37	2	MM17071
Pathway	BIOCARTA_HSWI_SNF_PATHWAY	NR3C1 ARID1A	4.35e-04	12	37	2	M22006
Pathway	REACTOME_PROLACTIN_RECEPTOR_SIGNALING	GH2 BTRC	6.89e-04	15	37	2	M552
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	HOXC8 ILF3 RSU1	9.12e-04	73	37	3	MM15126
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	TARDBP ILF3 BCLAF1 SMCHD1 DDX5	4.24e-07	109	48	5	29511296
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	TARDBP ILF3 MAGED1 BCLAF1 BTRC DDX5	1.08e-06	244	48	6	30349055
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	TARDBP ILF3 PUM1 BCLAF1 RBMS2 DDX5	1.49e-06	258	48	6	37794589
Pubmed	Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.	ARID1B ARID1A	1.87e-06	2	48	2	34386776
Pubmed	Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.	ARID1B ARID1A	1.87e-06	2	48	2	23202128
Pubmed	ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.	ARID1B ARID1A	1.87e-06	2	48	2	33890484
Pubmed	Expression of glucocorticoid receptor and early growth response gene 1 during postnatal development of two inbred strains of mice exposed to early life stress.	NR3C1 EGR1	1.87e-06	2	48	2	20453467
Pubmed	The MAPK pathway and Egr-1 mediate stress-related behavioral effects of glucocorticoids.	NR3C1 EGR1	1.87e-06	2	48	2	15834420
Pubmed	ARID1B is a specific vulnerability in ARID1A-mutant cancers.	ARID1B ARID1A	1.87e-06	2	48	2	24562383
Pubmed	Chromosomal localization of Celsr2 and Celsr3 in the mouse; Celsr3 is a candidate for the tippy (tip) lethal mutant on chromosome 9.	CELSR3 CELSR2	1.87e-06	2	48	2	10790539
Pubmed	Soluble Klotho regulates bone differentiation by upregulating expression of the transcription factor EGR-1.	KL EGR1	1.87e-06	2	48	2	31536138
Pubmed	Transcriptional activation of the human Klotho gene by epidermal growth factor in HEK293 cells; role of Egr-1.	KL EGR1	1.87e-06	2	48	2	19913601
Pubmed	Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.	ARID1B ARID1A	1.87e-06	2	48	2	37611161
Pubmed	Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.	ARID1B ARID1A	1.87e-06	2	48	2	32791957
Pubmed	ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.	ARID1B ARID1A	1.87e-06	2	48	2	29890703
Pubmed	Identification of DDX5 as an indispensable activator of the glucocorticoid receptor in adipocyte differentiation.	NR3C1 DDX5	1.87e-06	2	48	2	36071319
Pubmed	Quantitative trait loci for body weight in the intercross between SM/J and A/J mice.	NR3C1 EGR1	1.87e-06	2	48	2	11515095
Pubmed	SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.	ARID1B ARID1A	1.87e-06	2	48	2	24788099
Pubmed	Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.	ARID1B ARID1A	1.87e-06	2	48	2	28967863
Pubmed	Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.	ARID1B ARID1A	1.87e-06	2	48	2	33052929
Pubmed	Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.	ARID1B ARID1A	1.87e-06	2	48	2	27562491
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	TARDBP ILF3 PUM1 BCLAF1 SIRT3 DDX5	2.10e-06	274	48	6	34244482
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TARDBP ILF3 SUPT20H MAGED1 NR3C1 SMCHD1 DDX5	2.47e-06	444	48	7	34795231
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	TARDBP ILF3 PDLIM1 BCLAF1 SMCHD1 DDX5	2.54e-06	283	48	6	30585729
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	ARID1B NR3C1 ARID1A SMCHD1	4.23e-06	78	48	4	28611094
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TARDBP IARS2 ILF3 NR3C1 TTC1 PDLIM1 BCLAF1 SMCHD1 DDX5	4.58e-06	934	48	9	33916271
Pubmed	Genetic variation in healthy oldest-old.	APOB KL SIRT3	4.89e-06	24	48	3	19680556
Pubmed	Chromosomal localization of homeobox genes and associated markers on porcine chromosomes 3, 5, 12, 15, 16 and 18: comparative mapping study with human and mouse.	GH2 APOB HOXC8	4.89e-06	24	48	3	8833235
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TARDBP ARID1B ILF3 ARID1A PUM1 BCLAF1 SMCHD1 RBMS2 DDX5	5.43e-06	954	48	9	36373674
Pubmed	Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.	ARID1B ARID1A	5.59e-06	3	48	2	33432679
Pubmed	Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.	ARID1B ARID1A	5.59e-06	3	48	2	21647563
Pubmed	Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation.	NR3C1 ARID1A	5.59e-06	3	48	2	36344675
Pubmed	TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.	ARID1B ARID1A	5.59e-06	3	48	2	34044070
Pubmed	Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.	ARID1B ARID1A	5.59e-06	3	48	2	26716708
Pubmed	The methylated-DNA binding protein MBD2 enhances NGFI-A (egr-1)-mediated transcriptional activation of the glucocorticoid receptor.	NR3C1 EGR1	5.59e-06	3	48	2	25135974
Pubmed	The flamingo-related mouse Celsr family (Celsr1-3) genes exhibit distinct patterns of expression during embryonic development.	CELSR3 CELSR2	5.59e-06	3	48	2	11677057
Pubmed	Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.	ARID1B ARID1A	5.59e-06	3	48	2	22426308
Pubmed	Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.	ARID1B ARID1A	5.59e-06	3	48	2	24382590
Pubmed	ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.	ARID1B ARID1A	5.59e-06	3	48	2	34512623
Pubmed	Lysyl oxidase (Lox) maps between Grl-1 and Adrb-2 on mouse chromosome 18.	NR3C1 EGR1	1.12e-05	4	48	2	8094989
Pubmed	Klotho down-regulates Egr-1 by inhibiting TGF-β1/Smad3 signaling in high glucose treated human mesangial cells.	KL EGR1	1.12e-05	4	48	2	28411025
Pubmed	The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms.	CELSR3 CELSR2	1.12e-05	4	48	2	37224017
Pubmed	Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.	ARID1B ARID1A	1.12e-05	4	48	2	28863077
Pubmed	Inhibition of IRAK1 Ubiquitination Determines Glucocorticoid Sensitivity for TLR9-Induced Inflammation in Macrophages.	NR3C1 BTRC	1.12e-05	4	48	2	29038250
Pubmed	Two related ARID family proteins are alternative subunits of human SWI/SNF complexes.	ARID1B ARID1A	1.12e-05	4	48	2	15170388
Pubmed	Developmental expression profiles of Celsr (Flamingo) genes in the mouse.	CELSR3 CELSR2	1.12e-05	4	48	2	11850187
Pubmed	Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.	ARID1B ARID1A	1.12e-05	4	48	2	11988099
Pubmed	Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.	ILF3 BTRC DDX5	1.19e-05	32	48	3	36252997
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRL1 CELSR3 CELSR2	1.31e-05	33	48	3	25713288
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	TARDBP ARID1B ARID1A SMCHD1 DDX5	1.33e-05	220	48	5	35785414
Pubmed	Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases.	TARDBP MAGED1 DDX5	1.43e-05	34	48	3	16611982
Pubmed	The testis-specific double bromodomain-containing protein BRDT forms a complex with multiple spliceosome components and is required for mRNA splicing and 3'-UTR truncation in round spermatids.	TARDBP DDX5	1.86e-05	5	48	2	22570411
Pubmed	The HSA domain of BRG1 mediates critical interactions required for glucocorticoid receptor-dependent transcriptional activation in vivo.	NR3C1 ARID1A	1.86e-05	5	48	2	18086889
Pubmed	Recent advances in understanding chromatin remodeling by Swi/Snf complexes.	ARID1B ARID1A	1.86e-05	5	48	2	12672490
Pubmed	Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors.	ARID1B ARID1A	1.86e-05	5	48	2	12200431
Pubmed	LDL-cholesterol concentrations: a genome-wide association study.	APOB CELSR2	1.86e-05	5	48	2	18262040
Pubmed	Mapping of multiple intestinal neoplasia (Min) to proximal chromosome 18 of the mouse.	NR3C1 EGR1	1.86e-05	5	48	2	8094372
Pubmed	Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations.	ARID1B ARID1A	1.86e-05	5	48	2	38489371
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	TARDBP ILF3 ING3 ARID1A BCLAF1 DDX5	2.12e-05	411	48	6	35182466
Pubmed	Identification of Wilms' tumor 1-associating protein complex and its role in alternative splicing and the cell cycle.	VIRMA BCLAF1	2.79e-05	6	48	2	24100041
Pubmed	The p270 (ARID1A/SMARCF1) subunit of mammalian SWI/SNF-related complexes is essential for normal cell cycle arrest.	ARID1B ARID1A	2.79e-05	6	48	2	16230384
Pubmed	Numerous BAF complex genes are mutated in Coffin-Siris syndrome.	ARID1B ARID1A	2.79e-05	6	48	2	25081545
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	FANCD2 TARDBP APOB ILF3 BCLAF1 SMCHD1 DDX5	2.98e-05	652	48	7	31180492
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	TARDBP ILF3 ARID1A SMCHD1	3.29e-05	131	48	4	34551306
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	ARID1B MAGED1 TTC1 ARID1A PUM1 RSU1	3.35e-05	446	48	6	24255178
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	ARID1B SUPT20H ING3 ARID1A	3.59e-05	134	48	4	25452129
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	FANCD2 ARID1B ILF3 ARID1A EGR1 SMCHD1	3.65e-05	453	48	6	29656893
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	ARID1B ARID1A PUM1 RBMS2 DDX5 SLC30A6	3.83e-05	457	48	6	32344865
Pubmed	Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues.	CELSR3 CELSR2	3.90e-05	7	48	2	17937400
Pubmed	Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.	ARID1B ARID1A	3.90e-05	7	48	2	23540691
Pubmed	MAGED1 is a novel regulator of a select subset of bHLH PAS transcription factors.	MAGED1 ARNT2	3.90e-05	7	48	2	27472814
Pubmed	Fibroblast Growth Factor 2 Modulates Hypothalamic Pituitary Axis Activity and Anxiety Behavior Through Glucocorticoid Receptors.	NR3C1 EGR1	3.90e-05	7	48	2	27133954
Pubmed	Interactome analysis of the human Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (hMTr1) protein.	ILF3 BCLAF1 SMCHD1 DDX5	4.03e-05	138	48	4	30320910
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ILF3 MAGED1 BTRC SMCHD1 DDX5 ARHGAP12	4.75e-05	475	48	6	31040226
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	ARID1A VIRMA BCLAF1 DDX5	6.18e-05	154	48	4	16055720
Pubmed	Identification of high-molecular-weight proteins with multiple EGF-like motifs by motif-trap screening.	CELSR3 CELSR2	6.67e-05	9	48	2	9693030
Pubmed	Location of the 9257 and ataxia mutations on mouse chromosome 18.	NR3C1 EGR1	6.67e-05	9	48	2	8662222
Pubmed	Coffin-Siris Syndrome	ARID1B ARID1A	6.67e-05	9	48	2	23556151
Pubmed	Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B.	ARID1B ARID1A	6.67e-05	9	48	2	20086098
Pubmed	The BAF chromatin complex component SMARCC1 does not mediate GLI transcriptional repression of Hedgehog target genes in limb buds.	ARID1B ARID1A	6.67e-05	9	48	2	37805104
Pubmed	Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data.	APOB CELSR2	6.67e-05	9	48	2	20370913
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	FANCD2 CCNT2 TARDBP ILF3 SUPT20H VIRMA BCLAF1 SMCHD1	6.81e-05	1014	48	8	32416067
Pubmed	ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure.	TARDBP MAGED1 PUM1 PDLIM1 RBMS2	7.35e-05	315	48	5	26777405
Pubmed	Celsr3 is required in motor neurons to steer their axons in the hindlimb.	CELSR3 CELSR2	8.33e-05	10	48	2	25108913
Pubmed	Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner.	ARID1B ARID1A	8.33e-05	10	48	2	12665591
Pubmed	Nomenclature of the ARID family of DNA-binding proteins.	ARID1B ARID1A	8.33e-05	10	48	2	15922553
Pubmed	ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF.	ARID1B ARID1A	8.33e-05	10	48	2	23129809
Pubmed	DNA damage-induced activation of ATM promotes β-TRCP-mediated ARID1A ubiquitination and destruction in gastric cancer cells.	ARID1A BTRC	8.33e-05	10	48	2	31210753
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	TARDBP IARS2 MAGED1 NR3C1 TTC1 ARID1A BCLAF1 RBMS2 DDX5	9.16e-05	1367	48	9	32687490
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	FANCD2 APOB IARS2 MAGED1 CELSR2 PDLIM1 SIRT3 SMCHD1	9.33e-05	1061	48	8	33845483
Pubmed	A dual role for planar cell polarity genes in ciliated cells.	CELSR3 CELSR2	1.02e-04	11	48	2	25024228
Pubmed	Do Gametes Woo? Evidence for Their Nonrandom Union at Fertilization.	APOB PUM1	1.02e-04	11	48	2	28978771
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TARDBP ARID1B ARID1A PDLIM1 BCLAF1 SMCHD1	1.05e-04	549	48	6	38280479
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ARID1B ILF3 ARID1A BCLAF1 SMCHD1	1.07e-04	341	48	5	32971831
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CCNT2 TARDBP ARID1B ILF3 SUPT20H ARID1A BCLAF1 DDX5	1.07e-04	1082	48	8	38697112
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	TARDBP ILF3 PUM1 VIRMA BCLAF1 RBMS2 DDX5	1.14e-04	807	48	7	22681889
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CCNT2 ARID1B ILF3 ARID1A EGR1 BCLAF1 SMCHD1 DDX5	1.22e-04	1103	48	8	34189442
Pubmed	Arid1a regulates bladder urothelium formation and maintenance.	ARID1B ARID1A	1.22e-04	12	48	2	35283102
Pubmed	SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones.	ARID1B ARID1A	1.22e-04	12	48	2	11734557
Pubmed	Differential expression of the seven-pass transmembrane cadherin genes Celsr1-3 and distribution of the Celsr2 protein during mouse development.	CELSR3 CELSR2	1.22e-04	12	48	2	11891983
Interaction	HNRNPC interactions	FANCD2 TARDBP ILF3 ARID1A PUM1 VIRMA BCLAF1 BTRC RBMS2 DDX5	1.30e-06	634	46	10	int:HNRNPC
Interaction	IGF2BP2 interactions	FANCD2 TARDBP ILF3 PUM1 VIRMA CDC14A BTRC RBMS2	1.30e-06	357	46	8	int:IGF2BP2
Interaction	ALDH2 interactions	FANCD2 TARDBP IARS2 ARID1A BTRC SIRT3	1.31e-06	154	46	6	int:ALDH2
Interaction	TMED7 interactions	FANCD2 ADGRL1 CELSR3 VIRMA SLC30A6	1.34e-06	84	46	5	int:TMED7
Interaction	MATR3 interactions	FANCD2 TARDBP IARS2 ILF3 PUM1 VIRMA BCLAF1 BTRC SMCHD1 DDX5	1.74e-06	655	46	10	int:MATR3
Interaction	FMR1 interactions	FANCD2 ILF3 MAGED1 NR3C1 PUM1 VIRMA BCLAF1 BTRC DDX5	2.85e-06	536	46	9	int:FMR1
Interaction	RBFOX2 interactions	FANCD2 MAGED1 NR3C1 PUM1 BTRC RBMS2 DDX5	3.43e-06	284	46	7	int:RBFOX2
Interaction	AGO1 interactions	FANCD2 ILF3 PUM1 VIRMA RBMS2 DDX5	3.58e-06	183	46	6	int:AGO1
Interaction	RBX1 interactions	FANCD2 TARDBP ARID1B ILF3 MAGED1 ING3 BCLAF1 BTRC DDX5	3.96e-06	558	46	9	int:RBX1
Interaction	IL17RD interactions	NR3C1 VIRMA BTRC	4.97e-06	15	46	3	int:IL17RD
Interaction	PSMA3 interactions	FANCD2 ADGRL1 TARDBP ILF3 EGR1 VIRMA BTRC DDX5	6.42e-06	443	46	8	int:PSMA3
Interaction	MRPL41 interactions	FANCD2 ILF3 NR3C1 VIRMA BTRC RBMS2	6.87e-06	205	46	6	int:MRPL41
Interaction	FOXO3 interactions	FANCD2 ARID1A VIRMA BTRC SIRT3	9.11e-06	124	46	5	int:FOXO3
Interaction	MRPS27 interactions	FANCD2 TARDBP ILF3 NR3C1 VIRMA BTRC RBMS2	9.72e-06	333	46	7	int:MRPS27
Interaction	LPCAT1 interactions	FANCD2 ILF3 NR3C1 VIRMA BTRC	1.10e-05	129	46	5	int:LPCAT1
Interaction	FAM120A interactions	FANCD2 TARDBP ILF3 PUM1 VIRMA BTRC RBMS2	1.32e-05	349	46	7	int:FAM120A
Interaction	G3BP1 interactions	FANCD2 TARDBP MAGED1 PUM1 PDLIM1 EGR1 VIRMA BTRC RBMS2 DDX5	1.48e-05	835	46	10	int:G3BP1
Interaction	MDM2 interactions	APOB KL ILF3 ING3 NR3C1 EGR1 BTRC SIRT3 DDX5	1.49e-05	658	46	9	int:MDM2
Interaction	NYAP2 interactions	NR3C1 VIRMA DDX5	1.91e-05	23	46	3	int:NYAP2
Interaction	TLE3 interactions	ARID1B HOXC8 MAGED1 NR3C1 ARID1A EGR1 VIRMA	2.13e-05	376	46	7	int:TLE3
Interaction	ARID2 interactions	ARID1B NR3C1 ARID1A EGR1 VIRMA	2.52e-05	153	46	5	int:ARID2
Interaction	PRRC2A interactions	TARDBP MAGED1 PUM1 VIRMA CDC14A BTRC RBMS2	2.65e-05	389	46	7	int:PRRC2A
Interaction	HSPB1 interactions	FANCD2 TARDBP IARS2 ILF3 MAGED1 PUM1 PDLIM1 VIRMA BTRC	2.66e-05	708	46	9	int:HSPB1
Interaction	CAND1 interactions	FANCD2 TARDBP ZNF407 ARID1B ILF3 PUM1 VIRMA BCLAF1 BTRC DDX5	2.67e-05	894	46	10	int:CAND1
Interaction	H2BC19P interactions	FANCD2 NR3C1	3.05e-05	4	46	2	int:H2BC19P
Interaction	GLUL interactions	FANCD2 TARDBP VIRMA BTRC RBMS2	3.12e-05	160	46	5	int:GLUL
Interaction	QSOX2 interactions	FANCD2 ILF3 TTC1 VIRMA	3.15e-05	79	46	4	int:QSOX2
Interaction	LSM12 interactions	FANCD2 TARDBP PUM1 VIRMA BTRC	3.51e-05	164	46	5	int:LSM12
Interaction	XRCC6 interactions	FANCD2 TARDBP ILF3 PDLIM1 VIRMA BCLAF1 BTRC SIRT3 SMCHD1 DDX5	3.67e-05	928	46	10	int:XRCC6
Interaction	ATXN2L interactions	FANCD2 CCNT2 TARDBP PUM1 BTRC DDX5	4.51e-05	286	46	6	int:ATXN2L
Interaction	UPF1 interactions	FANCD2 TARDBP ILF3 PUM1 VIRMA BTRC RBMS2 DDX5	4.51e-05	581	46	8	int:UPF1
Interaction	NUP35 interactions	ARID1B ILF3 ARID1A PUM1 RBMS2 DDX5 SLC30A6	4.58e-05	424	46	7	int:NUP35
Interaction	ILF2 interactions	FANCD2 TARDBP IARS2 ILF3 PUM1 VIRMA BTRC DDX5	5.03e-05	590	46	8	int:ILF2
Interaction	ZFR interactions	TARDBP ILF3 VIRMA BTRC RBMS2 DDX5	5.99e-05	301	46	6	int:ZFR
Interaction	ELAVL2 interactions	TARDBP ILF3 NR3C1 PUM1 RBMS2	6.73e-05	188	46	5	int:ELAVL2
Interaction	ALDH18A1 interactions	FANCD2 ILF3 NR3C1 VIRMA SMCHD1	6.90e-05	189	46	5	int:ALDH18A1
Interaction	SOX9 interactions	ARID1B ARID1A VIRMA BTRC	7.05e-05	97	46	4	int:SOX9
Interaction	PSAT1 interactions	IARS2 ILF3 TTC1 VIRMA	7.05e-05	97	46	4	int:PSAT1
Interaction	SMCHD1 interactions	FANCD2 NR3C1 VIRMA CDC14A SMCHD1	7.26e-05	191	46	5	int:SMCHD1
Interaction	HNRNPH2 interactions	FANCD2 TARDBP IARS2 ILF3 VIRMA DDX5	7.30e-05	312	46	6	int:HNRNPH2
Interaction	ATXN2 interactions	TARDBP ILF3 PUM1 VIRMA RBMS2 DDX5	7.30e-05	312	46	6	int:ATXN2
Interaction	NPAS4 interactions	MAGED1 ARNT2	7.60e-05	6	46	2	int:NPAS4
Interaction	SMARCA4 interactions	FANCD2 ARID1B NR3C1 ARID1A EGR1 VIRMA DDX5	7.85e-05	462	46	7	int:SMARCA4
Interaction	DDX1 interactions	FANCD2 TARDBP ILF3 PUM1 VIRMA BTRC DDX5	7.96e-05	463	46	7	int:DDX1
Interaction	GLDC interactions	TARDBP ILF3 PUM1 BCLAF1 SIRT3 DDX5	8.54e-05	321	46	6	int:GLDC
Interaction	TADA2A interactions	ILF3 SUPT20H NR3C1 DDX5 ARNT2	8.60e-05	198	46	5	int:TADA2A
Interaction	SNRNP40 interactions	CCNT2 ARID1B ILF3 ARID1A PDLIM1 VIRMA BCLAF1 DDX5	8.61e-05	637	46	8	int:SNRNP40
Interaction	PRP4K interactions	CCNT2 ILF3 NR3C1 VIRMA BCLAF1 DDX5	9.77e-05	329	46	6	int:PRP4K
Interaction	PDCD6 interactions	TARDBP ARID1B NR3C1 ARID1A VIRMA	9.90e-05	204	46	5	int:PDCD6
Interaction	NANOG interactions	ARID1B ILF3 MAGED1 ARID1A PUM1 VIRMA BCLAF1	1.01e-04	481	46	7	int:NANOG
Interaction	CUL7 interactions	TARDBP APOB ILF3 PDLIM1 CDC14A BCLAF1 SMCHD1 SH3BP2 DDX5	1.05e-04	845	46	9	int:CUL7
Interaction	NRG2 interactions	FANCD2 VIRMA	1.06e-04	7	46	2	int:NRG2
Interaction	GPR135 interactions	MAGED1 VIRMA	1.06e-04	7	46	2	int:GPR135
Interaction	JUP interactions	FANCD2 TARDBP IARS2 ILF3 RIBC2 VIRMA BTRC	1.06e-04	485	46	7	int:JUP
Interaction	CDC5L interactions	FANCD2 TARDBP ILF3 ARID1A VIRMA CDC14A SMCHD1 RBMS2 DDX5	1.14e-04	855	46	9	int:CDC5L
Interaction	JCAD interactions	NR3C1 VIRMA CDC14A	1.20e-04	42	46	3	int:JCAD
Interaction	ZC3H11A interactions	FANCD2 TARDBP VIRMA BCLAF1 RBMS2	1.27e-04	215	46	5	int:ZC3H11A
Interaction	CYLD interactions	TARDBP MGAM ILF3 MAGED1 CFAP44 PDLIM1 VIRMA BCLAF1 DDX5	1.28e-04	868	46	9	int:CYLD
Interaction	DHX15 interactions	FANCD2 TARDBP ILF3 VIRMA RSU1 BTRC DDX5	1.32e-04	502	46	7	int:DHX15
Interaction	THOC2 interactions	FANCD2 TTC1 VIRMA BCLAF1 DDX5	1.38e-04	219	46	5	int:THOC2
Interaction	MRPL23 interactions	FANCD2 ILF3 NR3C1 VIRMA RBMS2	1.38e-04	219	46	5	int:MRPL23
Interaction	KPNA1 interactions	FANCD2 ILF3 SUPT20H ING3 NR3C1 BTRC	1.39e-04	351	46	6	int:KPNA1
Interaction	HNRNPUL1 interactions	FANCD2 TARDBP ILF3 VIRMA BTRC DDX5	1.39e-04	351	46	6	int:HNRNPUL1
Interaction	ZCCHC24 interactions	PUM1 VIRMA	1.41e-04	8	46	2	int:ZCCHC24
Interaction	FGF23 interactions	KL ILF3	1.41e-04	8	46	2	int:FGF23
Interaction	SIM1 interactions	MAGED1 ARNT2	1.41e-04	8	46	2	int:SIM1
Interaction	IGF2BP3 interactions	FANCD2 ILF3 PUM1 VIRMA BTRC RBMS2 DDX5	1.42e-04	508	46	7	int:IGF2BP3
Interaction	LUC7L2 interactions	FANCD2 TARDBP VIRMA BCLAF1 BTRC DDX5	1.44e-04	353	46	6	int:LUC7L2
Interaction	STAG2 interactions	FANCD2 NR3C1 VIRMA BCLAF1 DDX5	1.53e-04	224	46	5	int:STAG2
Interaction	FLRT1 interactions	ADGRL1 CELSR2 VIRMA	1.58e-04	46	46	3	int:FLRT1
Interaction	TOP1 interactions	FANCD2 TARDBP ILF3 NR3C1 ARID1A VIRMA BCLAF1 DDX5	1.59e-04	696	46	8	int:TOP1
Interaction	ANKRD17 interactions	HOXC8 ILF3 NR3C1 PUM1 VIRMA	1.60e-04	226	46	5	int:ANKRD17
Interaction	PABPC1 interactions	FANCD2 TARDBP ILF3 PUM1 VIRMA BTRC RBMS2 DDX5	1.63e-04	699	46	8	int:PABPC1
Interaction	HNRNPDL interactions	FANCD2 TARDBP ILF3 NR3C1 BTRC DDX5	1.70e-04	364	46	6	int:HNRNPDL
Interaction	RMRP interactions	ILF3 VIRMA	1.82e-04	9	46	2	int:RMRP
Interaction	SPSB4 interactions	CELSR3 CELSR2 TTC1 PUM1	1.82e-04	124	46	4	int:SPSB4
Interaction	NACA interactions	FANCD2 TARDBP VIRMA BTRC DDX5	1.88e-04	234	46	5	int:NACA
Interaction	TP53BP1 interactions	FANCD2 ARID1B ILF3 ARID1A EGR1 VIRMA SIRT3	1.90e-04	533	46	7	int:TP53BP1
Interaction	HNRNPR interactions	FANCD2 TARDBP ILF3 NR3C1 BTRC RBMS2 DDX5	1.97e-04	536	46	7	int:HNRNPR
Interaction	SYNCRIP interactions	FANCD2 TARDBP ILF3 PUM1 VIRMA BTRC RBMS2 DDX5	2.02e-04	721	46	8	int:SYNCRIP
Interaction	AATF interactions	ILF3 MAGED1 NR3C1 PUM1 BCLAF1 BTRC	2.02e-04	376	46	6	int:AATF
Interaction	MYCN interactions	TARDBP APOB ARID1B HOXC8 ILF3 ARID1A VIRMA BCLAF1 SMCHD1 RBMS2 DDX5	2.05e-04	1373	46	11	int:MYCN
Interaction	RPL23 interactions	FANCD2 PCDHB6 TARDBP ILF3 CELSR2 VIRMA BTRC	2.06e-04	540	46	7	int:RPL23
Interaction	KHDRBS2 interactions	TARDBP ILF3 BTRC DDX5	2.12e-04	129	46	4	int:KHDRBS2
Interaction	SPSB2 interactions	CELSR2 TTC1 PUM1	2.15e-04	51	46	3	int:SPSB2
Interaction	MRPL42 interactions	ILF3 TTC1 PDLIM1 SIRT3 RBMS2	2.20e-04	242	46	5	int:MRPL42
Interaction	MXRA5 interactions	NR3C1 VIRMA	2.27e-04	10	46	2	int:MXRA5
Interaction	WEE1 interactions	NR3C1 VIRMA CDC14A BTRC	2.39e-04	133	46	4	int:WEE1
Interaction	SFPQ interactions	FANCD2 TARDBP ILF3 NR3C1 VIRMA BTRC DDX5	2.66e-04	563	46	7	int:SFPQ
Interaction	KIAA0825 interactions	ILF3 VIRMA	2.77e-04	11	46	2	int:KIAA0825
Interaction	FUS interactions	FANCD2 TARDBP ILF3 ARID1A VIRMA BCLAF1 BTRC DDX5	2.81e-04	757	46	8	int:FUS
Interaction	ACTN4 interactions	FANCD2 ILF3 ARID1A PDLIM1 VIRMA SMCHD1	2.82e-04	400	46	6	int:ACTN4
Interaction	DDX39B interactions	FANCD2 TARDBP ILF3 VIRMA BCLAF1 BTRC DDX5	2.87e-04	570	46	7	int:DDX39B
Interaction	HELZ interactions	TARDBP MAGED1 PUM1 VIRMA RBMS2	2.90e-04	257	46	5	int:HELZ
Interaction	SLX4 interactions	FANCD2 TARDBP SUPT20H ING3 VIRMA SMCHD1 DDX5	2.93e-04	572	46	7	int:SLX4
Interaction	PBRM1 interactions	FANCD2 ARID1B NR3C1 ARID1A VIRMA	2.95e-04	258	46	5	int:PBRM1
Interaction	MYO10 interactions	MAGED1 VIRMA BCLAF1 BTRC	2.98e-04	141	46	4	int:MYO10
Interaction	NFIB interactions	FANCD2 ARID1B NR3C1 ARID1A	3.06e-04	142	46	4	int:NFIB
Interaction	PABPC5 interactions	TARDBP ILF3 PUM1 RBMS2	3.06e-04	142	46	4	int:PABPC5
Interaction	NAA40 interactions	TARDBP IARS2 ILF3 NR3C1 TTC1 PDLIM1 BCLAF1 SMCHD1 DDX5	3.13e-04	978	46	9	int:NAA40
Cytoband	1p21	CELSR2 CDC14A	2.91e-04	24	48	2	1p21
Cytoband	12q13.3	HOXC8 RBMS2	1.32e-03	51	48	2	12q13.3
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	1.29e-05	3	38	2	913
GeneFamily	Adhesion G protein-coupled receptors, subfamily C\|CELSR cadherins	CELSR3 CELSR2	1.29e-05	3	38	2	1189
GeneFamily	AT-rich interaction domain containing	ARID1B ARID1A	4.44e-04	15	38	2	418
Coexpression	NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	TARDBP EGR1 CDC14A SIRT3	1.82e-05	89	46	4	M41173
Coexpression	HUNSBERGER_EXERCISE_REGULATED_GENES	ADGRL1 MAGED1 EGR1	2.20e-05	31	46	3	M1878
Coexpression	GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN	CCNT2 ARID1B SUPT20H PDLIM1 EGR1	2.55e-05	199	46	5	M3569
Coexpression	GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN	CCNT2 ARID1B CELSR2 ARID1A SMCHD1	2.62e-05	200	46	5	M8088
Coexpression	GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP	PDE3B ARID1B PDLIM1 VIRMA SLC30A6	2.62e-05	200	46	5	M9317
Coexpression	CHEN_HOXA5_TARGETS_9HR_UP	CCNT2 SUPT20H ING3 EGR1 SMCHD1	4.40e-05	223	46	5	M17621
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ZNF407 PDE3B ARID1B CDC14A BCLAF1 SMCHD1	5.21e-08	188	48	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZNF407 PDE3B ARID1B CDC14A SMCHD1 DDX5	7.30e-08	199	48	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	ARID1B NR3C1 BCLAF1 SMCHD1 SH3BP2 DDX5	7.52e-08	200	48	6	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	IARS2 ARID1B ARID1A PUM1 CFAP44	9.69e-07	166	48	5	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ZNF407 APOB PDE3B CDC14A SMCHD1	1.12e-06	171	48	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	TARDBP ING3 SH3BP2 DDX5	9.74e-06	124	48	4	1483be8700eca7e2c288784a290d945d4022b17f
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	SLC36A1 CELSR2 EGR1 MS4A7	2.23e-05	153	48	4	5424494ea1f09542799045a875cc3eac13de5079
ToppCell	C_02\|World / shred on cell type and cluster	MEP1B MGAM APOB MS4A7	2.99e-05	165	48	4	a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 CELSR2 EGR1 DDX5	3.14e-05	167	48	4	b94e8ee8c3fcebedd8fcd719eadddc04c7513c50
ToppCell	ileum\|World / shred on tissue and cell subclass	MEP1B MGAM APOB MS4A7	3.36e-05	170	48	4	9f1211bd4287620e19a59f21e6ecdca3e42e0260
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR3C1 BCLAF1 SMCHD1 DDX5	4.02e-05	178	48	4	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	PDE3B ARID1B CDC14A SMCHD1	4.29e-05	181	48	4	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B SUPT20H CDC14A SMCHD1	4.58e-05	184	48	4	bd786db4dc4edae6d5cfc0b69901983dea19f729
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR3C1 EGR1 BCLAF1 SMCHD1	4.58e-05	184	48	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	ILEUM-inflamed-(1)_CD8_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PDE3B NR3C1 CDC14A TMIGD2	4.87e-05	187	48	4	a77d7ae44f47410bd92fb3aa0f44dce891752b63
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRL1 MAGED1 EGR1 DDX5	4.98e-05	188	48	4	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	facs-Pancreas-Endocrine-24m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRL1 MAGED1 EGR1 DDX5	5.08e-05	189	48	4	010fdd70e9d0e21b856306a29ff877776a480319
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRL1 MAGED1 EGR1 DDX5	5.29e-05	191	48	4	a251b134f67a0a1ef3a42f50042f128a17f20b22
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	PDE3B ARID1A PUM1 BCLAF1	5.51e-05	193	48	4	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 CSF2RA EGR1 DDX5	5.62e-05	194	48	4	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 CSF2RA EGR1 DDX5	5.62e-05	194	48	4	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B CDC14A TMIGD2 DDX5	5.73e-05	195	48	4	9c71d2a58e772b556e22e2f1d60593580b7aafd8
ToppCell	Enterocyte\|World / shred on cell type and cluster	MEP1B MGAM APOB MS4A7	5.97e-05	197	48	4	1dd980fd066aef21694395a4b69df938501d9631
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PDE3B CDC14A SMCHD1 DDX5	5.97e-05	197	48	4	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	BCLAF1 SMCHD1 SH3BP2 DDX5	5.97e-05	197	48	4	e666f6580e9a20b5e550f02125706db17eec8510
ToppCell	C_01\|World / shred on cell type and cluster	MEP1B MGAM APOB MS4A7	6.08e-05	198	48	4	71d38084d09a96331877384ce6346f0de4bdcef9
ToppCell	Enterocyte-C_01\|Enterocyte / shred on cell type and cluster	MEP1B MGAM APOB MS4A7	6.08e-05	198	48	4	4e2c30d6fd1d59db98a52bfcc3206b4c4ac5abe2
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3B CELSR3 CDC14A SMCHD1	6.08e-05	198	48	4	7608f67959e1cda7b10e57fd3af2f96216ebe7e9
ToppCell	COVID-19-COVID-19_Mild-Myeloid\|COVID-19_Mild / Disease, condition lineage and cell class	CSF2RA EGR1 MS4A7 SH3BP2	6.33e-05	200	48	4	247040492b3c327f4144fc94cf210dc04eecc7b0
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ARID1B ILF3 BCLAF1 SMCHD1	6.33e-05	200	48	4	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID1B BCLAF1 SMCHD1 DDX5	6.33e-05	200	48	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	5'-GW_trimst-1.5-SmallIntestine\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APOB HOXC8 NR3C1 PDLIM1	6.33e-05	200	48	4	3b6f964cf820f880c269c6fa004d9ee2929d8381
ToppCell	BAL-Control-cDC_4\|Control / Compartment, Disease Groups and Clusters	ADGRL1 TARDBP SIRT3	5.10e-04	145	48	3	3b2a2965dc18abd39d5ed70c0fcad0210e7f12c8
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	PDE3B ARID1B SMCHD1	5.31e-04	147	48	3	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MGAM CSF2RA CELSR3	5.52e-04	149	48	3	4de52569611e63a780cde9bd111d6d9c11a05a11
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MGAM CSF2RA CELSR3	5.52e-04	149	48	3	c957ac23ad6343eacce7e6be4a6d3ac043af4f86
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8\|bone_marrow / Manually curated celltypes from each tissue	PDE3B TMIGD2 RBMS2	6.08e-04	154	48	3	93145a1bc5712ae664690b03a9e00ce1f92cfc7e
ToppCell	facs-Brain_Myeloid-Cerebellum\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF2RA PDLIM1 MS4A7	6.31e-04	156	48	3	28c4fb4d2c6c47696c3a6722998f9da5a8923323
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	PDE3B CDC14A SMCHD1	6.31e-04	156	48	3	1545169694f686d28648a68b552c2ae606599d66
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF2RA MS4A7 SH3BP2	6.43e-04	157	48	3	c8f516d3f5622202d3f8514f68614cd86ea3f667
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF2RA MS4A7 SH3BP2	6.43e-04	157	48	3	4862a11ab8df27d26b4f1c1785e544a2d5b6db6e
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF2RA MS4A7 SH3BP2	6.43e-04	157	48	3	a0ec1628ce29841889f1d9d4ee9422921af7b0b5
ToppCell	facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CSF2RA MS4A7 SH3BP2	6.54e-04	158	48	3	7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00
ToppCell	facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CSF2RA MS4A7 SH3BP2	6.54e-04	158	48	3	b35bab2b93d0af821bfae18a358eb7dddaf3860f
ToppCell	Healthy/Control-CD8+_T_naive\|World / Disease group and Cell class	PDE3B RIBC2 TMIGD2	6.54e-04	158	48	3	70680b29428b6bf882b1fae36f924b775961176b
ToppCell	Healthy/Control-CD8+_T_naive\|Healthy/Control / Disease group and Cell class	PDE3B RIBC2 TMIGD2	6.79e-04	160	48	3	e1386c21fcbbf57fa32d8bdfba3cb1887477ff73
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NR3C1 CDC14A SIRT3	6.79e-04	160	48	3	529034a1101d7772d82f86beb5c6fa9c9dd97067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF407 PDE3B CDC14A	6.91e-04	161	48	3	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	PDE3B CDC14A SMCHD1	7.04e-04	162	48	3	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEP1B MGAM APOB	7.04e-04	162	48	3	de0fde4310a56dc96bfc134c44d104993526d9bc
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B NR3C1 CDC14A	7.04e-04	162	48	3	80317c4253bf8e897782e562f29835f181c65b98
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-ILC3\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KL CELSR3 TMIGD2	7.29e-04	164	48	3	631ec9f54475dcc9d6b1c5bf6917e7fda4671034
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 EGR1 DDX5	7.55e-04	166	48	3	66026988509e39e41274fa0de738383219e8ff30
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	CFAP44 RIBC2 MS4A7	7.68e-04	167	48	3	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B NR3C1 CDC14A	7.68e-04	167	48	3	4b6853efefea5178280ba7c31facda0fbd1cc469
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3B MS4A7 SH3BP2	7.68e-04	167	48	3	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEP1B MGAM APOB	7.82e-04	168	48	3	b14fd50232887b6dca1f39014d43c6f66e5c3b5c
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Th17\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RIBC2 TMIGD2 SLC30A6	7.82e-04	168	48	3	97bf074b91c9ae0064edc31fa4a2658ffdcfefa3
ToppCell	390C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MAGED1 RIBC2 TMIGD2	8.37e-04	172	48	3	3f894c74916d49a995b2d4651ca1c6733c14ce9c
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF2RA MS4A7 SH3BP2	8.51e-04	173	48	3	054f64462b648ba6b4b28b48c716dc01b2ddd790
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CSF2RA MS4A7 SH3BP2	8.51e-04	173	48	3	985068b149489b731a305ea9a5cfce8eafc9d289
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF2RA MS4A7 SH3BP2	8.51e-04	173	48	3	a664dbd7fb55b1c4309fa5f9425bc83924dac545
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CSF2RA MS4A7 SH3BP2	8.51e-04	173	48	3	34416c583eaa21ce447d9b67bb420e35d05acc25
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSF2RA MS4A7 SH3BP2	8.51e-04	173	48	3	9a8fec9a08bb61456a4ea43ae1316bd3e197a773
ToppCell	10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT\|blood / Manually curated celltypes from each tissue	PDE3B CDC14A TMIGD2	8.80e-04	175	48	3	b4e4b66e89f79999768a6192c8404cb2465f920b
ToppCell	Basal-basal-3\|World / Class top	PCDHB6 EGR1 DDX5	8.80e-04	175	48	3	a0d7ced5204a9efbbb91ac99410a088f8ed2df0f
ToppCell	ileum-Absorptive_Enterocytes\|ileum / shred on tissue and cell subclass	MGAM APOB	8.90e-04	41	48	2	650cec538c6acd92f45d804b3c94248c6231aa21
ToppCell	390C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	MAGED1 RIBC2 TMIGD2	8.94e-04	176	48	3	aab9603b7943b7f7243eb6190ebba998566196f3
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CSF2RA MS4A7 SH3BP2	9.09e-04	177	48	3	1e7b4c0e41649d57a2c219a3b7e693538b8b34e4
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV7-4-1 EGR1 ARNT2	9.09e-04	177	48	3	75cb2067a3f2d1b5a964890b02b604d1e79bd163
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE3B CFAP44 TMIGD2	9.24e-04	178	48	3	0290868dc990878eac5c182fe64968333bc52450
ToppCell	facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FANCD2 MEP1B SIRT3	9.39e-04	179	48	3	5297f7459b40ca780a1983fecc1bb9c035c7677e
ToppCell	Ciliated_cells-A-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	CFAP44 RIBC2 CDC14A	9.39e-04	179	48	3	1c41314b6fcfcac8d62034e7037570120d58f20f
ToppCell	Control-Myeloid-Dendritic_cells\|Control / group, cell type (main and fine annotations)	MGAM CSF2RA MS4A7	9.54e-04	180	48	3	25ad95c3c30e3b82abe93bd77ba003f5c2241f7c
ToppCell	COVID-19_Severe-Neutrophil-\|COVID-19_Severe / Disease condition and Cell class	MGAM EGR1 SMCHD1	9.70e-04	181	48	3	5e5101195d5ff8c8ea7ddcf0bc4f4e03e64c01e0
ToppCell	COVID-19-T_cells-Tregs\|COVID-19 / group, cell type (main and fine annotations)	PDE3B CDC14A SMCHD1	9.70e-04	181	48	3	534659cf754326c6a73c0daa30e9d610612a0292
ToppCell	COVID-19_Severe-Neutrophil\|COVID-19_Severe / Disease condition and Cell class	MGAM EGR1 SMCHD1	9.70e-04	181	48	3	aa5e5fb0308b5e2ef918548c85529c9a433c57f5
ToppCell	facs-Kidney-nan-3m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 EGR1 CDC14A	9.85e-04	182	48	3	4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR3C1 EGR1 SMCHD1	9.85e-04	182	48	3	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	EGR1 CDC14A TMIGD2	9.85e-04	182	48	3	b86690c109cdc16844a6cd2216c1bf2bf28efd45
ToppCell	Ciliated_cells-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CFAP44 RIBC2 MS4A7	9.85e-04	182	48	3	e93968f800bfeb258e4e834fc8bf92d1cb72cd73
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV7-4-1 EGR1 ARNT2	1.00e-03	183	48	3	ec2af3402b51f11466d2a5783a6b33746b6a7fc9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B CDC14A TMIGD2	1.00e-03	183	48	3	f2ef110bf29b1a8276ef216238363e542db262c1
ToppCell	ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PDE3B CDC14A BCLAF1	1.02e-03	184	48	3	cef3ee2a4a0af961aa3b4c92150d423e841ae8c1
ToppCell	3'-Adult-SmallIntestine-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEP1B MGAM APOB	1.02e-03	184	48	3	ed7a8e79e5723a5f5a03f542203d9e50bdef5f50
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B CDC14A TMIGD2	1.02e-03	184	48	3	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	droplet-Kidney-nan-18m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOB KL EGR1	1.02e-03	184	48	3	e02859bbac36dbbd55d7ae8cb5e46b764d7c6381
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR3C1 EGR1 SMCHD1	1.03e-03	185	48	3	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	COVID_non-vent-Myeloid-Monocytic-Neutrophil\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	MGAM EGR1 SMCHD1	1.03e-03	185	48	3	2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Monocytes\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CSF2RA MS4A7 SH3BP2	1.03e-03	185	48	3	f8de11dd53b34d36368a2082f24ec1416cb7dbae
ToppCell	5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE3B CDC14A SMCHD1	1.03e-03	185	48	3	8314dc608bc837df3037e89afd9db39737374ebc
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAGED1 NR3C1 TMIGD2	1.03e-03	185	48	3	308a98f111895071d8772bc010554471cc12fab2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE3B CDC14A TMIGD2	1.05e-03	186	48	3	c793a3d5709ad504c12fc3b2337746d90236d3ca
ToppCell	facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_A_+_HSC\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDLIM1 EGR1 SIRT3	1.05e-03	186	48	3	f14722ecc832794dc267bf3f9b8a13274c3addc1
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID1B ARID1A PUM1	1.05e-03	186	48	3	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEP1B MGAM APOB	1.05e-03	186	48	3	bdd9d3a432aab46e733469b362f0064d35c1ac49
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID1B ARID1A PUM1	1.05e-03	186	48	3	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MGAM KL SH3BP2	1.05e-03	186	48	3	5784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	PDE3B CDC14A SMCHD1	1.06e-03	187	48	3	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MEP1B MGAM APOB	1.06e-03	187	48	3	9042bd0f57213a51503d9df2e4dce3209b7772d3
Drug	troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A	CCNT2 PDE3B SUPT20H SIRT3 SMCHD1 RBMS2	2.57e-06	195	46	6	1657_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ADGRL1 EGR1 CDC14A SIRT3 SMCHD1 SH3BP2	2.65e-06	196	46	6	3422_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A	MGAM NR3C1 CELSR3 RIBC2 CDC14A SIRT3	2.73e-06	197	46	6	7482_UP
Drug	Betazole hydrochloride; Up 200; 27uM; MCF7; HT_HG-U133A	HOXC8 SUPT20H NR3C1 CFAP44 CDC14A SIRT3	2.81e-06	198	46	6	1690_UP
Drug	Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	CCNT2 NR3C1 PUM1 EGR1 SMCHD1	2.15e-05	167	46	5	4801_UP
Drug	AC1NARH5	MGAM NR3C1	2.39e-05	4	46	2	CID004456504
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	CCNT2 ING3 ARID1A PUM1 ARHGAP12	3.42e-05	184	46	5	2321_DN
Drug	Isoconazole [27523-40-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ZNF407 PDE3B HOXC8 ARID1A EGR1	3.70e-05	187	46	5	7211_UP
Drug	Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A	CCNT2 ADGRL1 PDE3B RIBC2 CDC14A	4.09e-05	191	46	5	2857_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	ZNF407 PDE3B NR3C1 ARID1A BTRC	4.51e-05	195	46	5	4748_DN
Drug	Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A	CCNT2 HOXC8 SUPT20H CFAP44 EGR1	4.51e-05	195	46	5	3455_UP
Drug	Clidinium bromide [3485-62-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PDE3B NR3C1 CELSR3 RIBC2 BTRC	4.51e-05	195	46	5	3476_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	PDE3B CELSR3 BTRC SIRT3 SH3BP2	4.51e-05	195	46	5	2283_DN
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	ADGRL1 PDE3B SLC36A1 RIBC2 EGR1	4.51e-05	195	46	5	7225_DN
Drug	Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A	PDE3B NR3C1 CELSR2 ARID1A BTRC	4.51e-05	195	46	5	5405_UP
Drug	Piperine [94-62-2]; Up 200; 14uM; MCF7; HT_HG-U133A	CCNT2 ADGRL1 PDE3B EGR1 SH3BP2	4.62e-05	196	46	5	3263_UP
Drug	Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ADGRL1 PDE3B HOXC8 BTRC SIRT3	4.62e-05	196	46	5	6844_DN
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	CCNT2 PDE3B RIBC2 BTRC SH3BP2	4.62e-05	196	46	5	6772_DN
Drug	Betamethasone [378-44-9]; Down 200; 10.2uM; PC3; HT_HG-U133A	ADGRL1 RIBC2 CDC14A BTRC SH3BP2	4.62e-05	196	46	5	6728_DN
Drug	ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA	NR3C1 ARID1A EGR1 BTRC SIRT3	4.62e-05	196	46	5	918_UP
Drug	Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; PC3; HT_HG-U133A	ADGRL1 RIBC2 CDC14A SIRT3 ARHGAP12	4.62e-05	196	46	5	6354_DN
Drug	Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; PC3; HT_HG-U133A	PDE3B KL CELSR2 BTRC SH3BP2	4.62e-05	196	46	5	6704_UP
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	CCNT2 CFAP44 CDC14A BTRC SH3BP2	4.62e-05	196	46	5	2288_DN
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A	CCNT2 ARID1A EGR1 SIRT3 ARNT2	4.62e-05	196	46	5	5807_UP
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A	PDE3B ARID1A RIBC2 BTRC SIRT3	4.74e-05	197	46	5	1526_DN
Drug	Iopanoic acid [96-83-3]; Up 200; 7uM; PC3; HT_HG-U133A	ADGRL1 PDE3B CELSR2 ARID1A CDC14A	4.74e-05	197	46	5	6348_UP
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A	ADGRL1 SUPT20H CDC14A RBMS2 SH3BP2	4.74e-05	197	46	5	4474_DN
Drug	SC 19220; Down 200; 10uM; MCF7; HT_HG-U133A	HOXC8 NR3C1 EGR1 RBMS2 SH3BP2	4.74e-05	197	46	5	7060_DN
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CCNT2 ADGRL1 NR3C1 RIBC2 EGR1	4.74e-05	197	46	5	5343_DN
Drug	Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A	ADGRL1 PDE3B CELSR3 BTRC SIRT3	4.74e-05	197	46	5	2868_DN
Drug	gentamicin	GH2 TARDBP MGAM APOB CSF2RA	4.85e-05	198	46	5	CID000003467
Drug	Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; PC3; HT_HG-U133A	ADGRL1 CELSR3 ARID1A CFAP44 SMCHD1	4.85e-05	198	46	5	1799_UP
Drug	Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CFAP44 EGR1 BTRC SIRT3 SH3BP2	4.85e-05	198	46	5	7331_UP
Drug	Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ADGRL1 SUPT20H NR3C1 EGR1 SH3BP2	4.85e-05	198	46	5	2281_DN
Drug	Zidovudine, AZT [30516-87-1]; Up 200; 15uM; MCF7; HT_HG-U133A	PDE3B KL ARID1A EGR1 BTRC	4.85e-05	198	46	5	3211_UP
Drug	Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A	PDE3B HOXC8 CDC14A BTRC SH3BP2	4.85e-05	198	46	5	6816_DN
Drug	Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A	ADGRL1 PDE3B CELSR3 CDC14A SH3BP2	4.97e-05	199	46	5	2862_DN
Drug	Methyldopate hydrochloride [2508-79-4]; Down 200; 14.6uM; PC3; HT_HG-U133A	CCNT2 ADGRL1 ZNF407 CELSR3 BTRC	4.97e-05	199	46	5	6640_DN
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	ADGRL1 ZNF407 SUPT20H RIBC2 SIRT3	4.97e-05	199	46	5	7125_UP
Drug	Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	HOXC8 NR3C1 EGR1 CDC14A SIRT3	4.97e-05	199	46	5	3349_DN
Drug	Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ILF3 RIBC2 EGR1 BTRC SIRT3	4.97e-05	199	46	5	7418_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	CCNT2 PDE3B CELSR3 CFAP44 RBMS2	4.97e-05	199	46	5	5542_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A	CCNT2 TARDBP PDE3B NR3C1 RBMS2	4.97e-05	199	46	5	1493_DN
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A	CCNT2 ADGRL1 BTRC SIRT3 SH3BP2	5.09e-05	200	46	5	1490_DN
Drug	Propylthiouracil [51-52-5]; Down 200; 23.4uM; PC3; HT_HG-U133A	ADGRL1 ZNF407 RIBC2 EGR1 SIRT3	5.09e-05	200	46	5	4076_DN
Drug	Isometheptene mucate; Up 200; 8.2uM; HL60; HT_HG-U133A	ZNF407 HOXC8 CELSR3 CDC14A SIRT3	5.09e-05	200	46	5	3145_UP
Drug	Pivampicillin [33817-20-8]; Up 200; 8.6uM; MCF7; HT_HG-U133A	ADGRL1 ZNF407 NR3C1 EGR1 BTRC	5.09e-05	200	46	5	5465_UP
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ZNF407 PDE3B HOXC8 ILF3 BTRC	5.09e-05	200	46	5	7031_UP
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	ADGRL1 ARID1A RIBC2 EGR1 ARNT2	5.09e-05	200	46	5	3827_DN
Drug	methenamine silver	APOB CELSR3 CELSR2 TTC1 RBMS2	5.21e-05	201	46	5	CID000004101
Drug	SCH 48461	MGAM APOB	5.96e-05	6	46	2	CID000132832
Drug	2,6-t	GH2 KL	1.42e-04	9	46	2	CID000011331
Drug	diopside	FANCD2 MGAM	1.78e-04	10	46	2	CID000166740
Drug	AC1L2UHE	APOB ILF3 EGR1	1.88e-04	55	46	3	CID000128814
Drug	arsenic(V	MGAM NR3C1	2.17e-04	11	46	2	CID000104737
Drug	thiazolidinedione	MGAM APOB PDE3B NR3C1 EGR1	2.23e-04	274	46	5	CID000005437
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	CCNT2 NR3C1 PUM1 EGR1	3.05e-04	160	46	4	4404_UP
Drug	5-phenylhydantoin	GH2 NR3C1	3.07e-04	13	46	2	CID000001002
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	CCNT2 NR3C1 PUM1 EGR1	3.35e-04	164	46	4	3963_UP
Drug	Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A	CCNT2 PUM1 EGR1 SMCHD1	3.50e-04	166	46	4	5324_UP
Drug	YS06	MGAM APOB	3.58e-04	14	46	2	CID000484586
Drug	olivine	FANCD2 MGAM	3.58e-04	14	46	2	CID006336632
Drug	AC1NSXE4	MGAM APOB	3.58e-04	14	46	2	CID005318881
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	CCNT2 ZNF407 NR3C1 EGR1	3.83e-04	170	46	4	4680_UP
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A	CCNT2 NR3C1 PUM1 EGR1	3.92e-04	171	46	4	3297_UP
Drug	5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA	CCNT2 EGR1 SIRT3 SH3BP2	4.10e-04	173	46	4	949_UP
Drug	Vancomycin	MEP1B MGAM KL SLC36A1 CSF2RA PDLIM1 EGR1 SIRT3	4.15e-04	906	46	8	ctd:D014640
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A	ING3 RIBC2 EGR1 ARNT2	4.28e-04	175	46	4	4651_UP
Drug	Mercuric Chloride	TARDBP APOB ILF3 NR3C1 EGR1 VIRMA BTRC DDX5 ARNT2	4.34e-04	1155	46	9	ctd:D008627
Drug	Glucose	MGAM ZNF407 APOB IARS2 NR3C1 EGR1 BTRC SIRT3 RBMS2 SH3BP2	4.46e-04	1420	46	10	ctd:D005947
Drug	NSC-634462	ADGRL1 PDE3B	4.71e-04	16	46	2	CID000366135
Drug	resveratrol; Up 200; 10uM; MCF7; HT_HG-U133A_EA	NR3C1 CELSR3 CFAP44 SIRT3	5.27e-04	185	46	4	841_UP
Drug	GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A	ZNF407 HOXC8 EGR1 BTRC	5.49e-04	187	46	4	3240_UP
Drug	Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A	CCNT2 PDE3B EGR1 BTRC	5.49e-04	187	46	4	5294_UP
Drug	Environmental Pollutants	APOB KL ILF3 CSF2RA PDLIM1 EGR1	5.54e-04	513	46	6	ctd:D004785
Drug	Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A	HOXC8 NR3C1 EGR1 SH3BP2	5.83e-04	190	46	4	1483_UP
Drug	5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA	NR3C1 CELSR3 CFAP44 BTRC	5.83e-04	190	46	4	970_UP
Drug	Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; PC3; HT_HG-U133A	APOB EGR1 BTRC ARNT2	5.95e-04	191	46	4	4613_UP
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	CCNT2 ADGRL1 SUPT20H SIRT3	5.95e-04	191	46	4	2850_DN
Drug	LY 294002; Up 200; 10uM; PC3; HT_HG-U133A	CELSR3 CELSR2 ARID1A SH3BP2	5.95e-04	191	46	4	1227_UP
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	ADGRL1 NR3C1 BTRC ARHGAP12	5.95e-04	191	46	4	1663_UP
Drug	Ethynodiol diacetate [297-76-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ADGRL1 ZNF407 PDE3B CDC14A	5.95e-04	191	46	4	6479_UP
Drug	AC1L1ALB	FANCD2 MGAM	5.99e-04	18	46	2	CID000001039
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SUPT20H NR3C1 ARID1A SMCHD1	6.06e-04	192	46	4	6207_DN
Drug	Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A	ADGRL1 PDE3B NR3C1 CFAP44	6.06e-04	192	46	4	2831_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	HOXC8 CELSR3 ARID1A SH3BP2	6.06e-04	192	46	4	2450_DN
Drug	0175029-0000 [211245-78-2]; Up 200; 1uM; PC3; HT_HG-U133A	CCNT2 ADGRL1 SUPT20H BTRC	6.06e-04	192	46	4	7392_UP
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	CCNT2 EGR1 CDC14A SIRT3	6.06e-04	192	46	4	2813_UP
Drug	troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	HOXC8 NR3C1 CFAP44 EGR1	6.18e-04	193	46	4	6949_UP
Drug	Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ADGRL1 RIBC2 CDC14A SH3BP2	6.18e-04	193	46	4	4122_UP
Drug	Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A	CELSR2 ARID1A SH3BP2 ARNT2	6.18e-04	193	46	4	3086_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; MCF7; HT_HG-U133A	PDE3B HOXC8 CELSR3 SIRT3	6.18e-04	193	46	4	3197_DN
Drug	Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A	APOB NR3C1 ARID1A EGR1	6.18e-04	193	46	4	3348_UP
Drug	Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A	ZNF407 NR3C1 EGR1 BTRC	6.18e-04	193	46	4	7176_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	PDE3B CFAP44 RIBC2 BTRC	6.18e-04	193	46	4	5215_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ADGRL1 PDE3B CELSR3 SH3BP2	6.18e-04	193	46	4	7232_DN
Drug	Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A	CCNT2 ADGRL1 HOXC8 BTRC	6.30e-04	194	46	4	6072_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	ADGRL1 SUPT20H CELSR3 ARID1A	6.30e-04	194	46	4	1060_UP
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	ADGRL1 HOXC8 CELSR2 SIRT3	6.30e-04	194	46	4	4246_DN
Drug	(-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	HOXC8 BTRC SIRT3 SH3BP2	6.30e-04	194	46	4	3354_DN
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B ARID1A	2.58e-05	5	48	2	C3281201
Disease	antihyperlipidemic drug use measurement	MEP1B APOB CELSR2 ARID1A	3.73e-05	115	48	4	EFO_0803367
Disease	LDL cholesterol change measurement	APOB CELSR2	5.41e-05	7	48	2	EFO_0007804
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	APOB CELSR2	7.21e-05	8	48	2	EFO_0008589, EFO_0008595
Disease	triglycerides in medium VLDL measurement	APOB CELSR2 ARID1A	9.99e-05	55	48	3	EFO_0022155
Disease	phospholipids in medium HDL measurement	APOB CELSR2 ARID1A	9.99e-05	55	48	3	EFO_0022295
Disease	neuroblastoma (is_implicated_in)	ARID1B ARID1A	1.16e-04	10	48	2	DOID:769 (is_implicated_in)
Disease	abdominal obesity-metabolic syndrome (implicated_via_orthology)	SIRT3 DDX5	1.16e-04	10	48	2	DOID:0060611 (implicated_via_orthology)
Disease	total lipids in medium HDL measurement	APOB CELSR2 ARID1A	1.17e-04	58	48	3	EFO_0022310
Disease	cholesterol in medium HDL measurement	APOB CELSR2 ARID1A	1.23e-04	59	48	3	EFO_0021903
Disease	total lipids in VLDL measurement	APOB CELSR2 ARID1A	1.30e-04	60	48	3	EFO_0022314
Disease	phospholipids in HDL measurement	APOB CELSR2 ARID1A	1.36e-04	61	48	3	EFO_0022293
Disease	triglycerides in medium LDL measurement	APOB CELSR2 ARID1A	1.43e-04	62	48	3	EFO_0022322
Disease	triglycerides in small LDL measurement	APOB CELSR2 ARID1A	1.64e-04	65	48	3	EFO_0022323
Disease	cholesterol in large VLDL measurement	APOB CELSR2 ARID1A	1.64e-04	65	48	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	APOB CELSR2 ARID1A	1.64e-04	65	48	3	EFO_0022230
Disease	total lipids in large VLDL	APOB CELSR2 ARID1A	1.80e-04	67	48	3	EFO_0022175
Disease	free cholesterol in large VLDL measurement	APOB CELSR2 ARID1A	1.88e-04	68	48	3	EFO_0022265
Disease	mitochondrial heteroplasmy measurement	MGAM CSF2RA DDX5	1.96e-04	69	48	3	EFO_0600008
Disease	Coffin-Siris syndrome	ARID1B ARID1A	2.00e-04	13	48	2	C0265338
Disease	congenital hypothyroidism (biomarker_via_orthology)	GH2 EGR1	2.33e-04	14	48	2	DOID:0050328 (biomarker_via_orthology)
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB CELSR2	2.33e-04	14	48	2	EFO_0004611, EFO_0008589
Disease	Hypertriglyceridemia	APOB CELSR2	2.68e-04	15	48	2	C0020557
Disease	response to statin, LDL cholesterol change measurement	APOB CELSR2	2.68e-04	15	48	2	EFO_0007804, GO_0036273
Disease	cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2	3.47e-04	17	48	2	EFO_0022232
Disease	very low density lipoprotein cholesterol measurement, esterified cholesterol measurement	APOB CELSR2	3.90e-04	18	48	2	EFO_0008317, EFO_0008589
Disease	sodium-coupled monocarboxylate transporter 1 measurement	APOB CELSR2	4.35e-04	19	48	2	EFO_0802076
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	APOB CELSR2	5.34e-04	21	48	2	EFO_0022246
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	APOB CELSR2 ARID1A	5.68e-04	99	48	3	EFO_0004611, EFO_0007878
Disease	coronary artery disease (is_implicated_in)	APOB KL NR3C1	5.85e-04	100	48	3	DOID:3393 (is_implicated_in)
Disease	progranulin measurement	ADGRL1 CELSR2	5.86e-04	22	48	2	EFO_0004625
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	APOB CELSR2 ARID1A	6.20e-04	102	48	3	EFO_0004329, EFO_0004611
Disease	familial hyperlipidemia	APOB CELSR2 ARID1A	6.93e-04	106	48	3	MONDO_0001336
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	APOB CELSR2 ARID1A	7.12e-04	107	48	3	EFO_0004614, EFO_0004615
Disease	lipoprotein A measurement	APOB ARID1B CELSR2	8.13e-04	112	48	3	EFO_0006925
Disease	cancer (implicated_via_orthology)	ARID1B ING3 ARID1A DDX5	9.46e-04	268	48	4	DOID:162 (implicated_via_orthology)
Disease	sleep duration, high density lipoprotein cholesterol measurement	APOB CELSR2 ARNT2	1.02e-03	121	48	3	EFO_0004612, EFO_0005271
Disease	angina pectoris	APOB CELSR2 SIRT3	1.12e-03	125	48	3	EFO_0003913
Disease	Hirschsprung Disease	ARID1B CELSR3	1.17e-03	31	48	2	C0019569
Disease	cholesteryl esters to total lipids in large LDL percentage	APOB CELSR2	1.17e-03	31	48	2	EFO_0022249
Disease	pulmonary sarcoidosis (is_marker_for)	NR3C1 EGR1	1.25e-03	32	48	2	DOID:13406 (is_marker_for)
Disease	Liver carcinoma	FANCD2 ARID1B CELSR3 ARID1A EGR1	1.37e-03	507	48	5	C2239176
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	APOB CELSR2	1.41e-03	34	48	2	EFO_0008317, EFO_0008596, EFO_0020947
Disease	lung disease (biomarker_via_orthology)	NR3C1 EGR1	1.49e-03	35	48	2	DOID:850 (biomarker_via_orthology)
Disease	hemoglobin A1 measurement	GH2 MGAM PDE3B KL CDC14A	1.53e-03	520	48	5	EFO_0007629
Disease	cholesteryl esters to total lipids in very large HDL percentage	APOB CELSR2	1.58e-03	36	48	2	EFO_0022257

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLSGSQYNINFQQGP	CCNT2	371	O60583
YNRSSNSNGGNLNSP	CDC14A	536	Q9UNH5
TLPLNGNFNNSYSLR	ADGRL1	1241	O94910
GNFNNSYSLRSGDFP	ADGRL1	1246	O94910
YNPGTGALTAFQNSS	BTRC	41	Q9Y297
SASPQGAFSLSGYNR	SH3BP2	66	P78314
FQQSNSSGTYGPQMS	ARID1B	901	Q8NFD5
NNYVTNRSSSFPGGA	CELSR2	1031	Q9HCU4
FNYSGNLLASVGSNP	CFAP44	236	Q96MT7
GNAYSSLANRTPGFA	ARNT2	626	Q9HBZ2
TSRPGISTFGYNRNN	RBMS2	6	Q15434
NQLLTSPSSARGYQG	ARID1A	296	O14497
FTLQGSYNQPLGLSS	KIAA0100	501	Q14667
GPNATYNFSQSLNAN	MAGED1	156	Q9Y5V3
FNRDTTPNGNGTNLY	MGAM	286	O43451
TSFRTGNPTGTYQNG	DDX5	556	P17844
QSQAFPGSAGTALQY	EGR1	221	P18146
SNNAYNVNSSQPLGS	ING3	196	Q9NXR8
NVNSSQPLGSYNIGS	ING3	201	Q9NXR8
YSNNPGSSFSSTQSQ	MS4A7	211	Q9GZW8
SSQGCYLNGPFNSNL	PDE3B	471	Q13370
LNFPGRTVFSNGYSS	NR3C1	381	P04150
TNQPTGDYFTQFNTG	RIBC2	366	Q9H4K1
FGPSYNQGQTVNLSL	ARHGAP12	136	Q8IWW6
PNNNLASSSFYGNNS	PUM1	636	Q14671
NTNTGNPTYAQGFTG	IGHV7-4-1	71	A0A0J9YVY3
RFNSSYLQGTNQITG	APOB	1521	P04114
SVGNGSSRYSPSQNS	BCLAF1	276	Q9NYF8
PSSYQSSQGGYGRNA	ILF3	871	Q12906
GISNSGYQQNPCSLS	HOXC8	66	P31273
LYNTSFRPTQGGQVS	KL	281	Q9UEF7
FNNYVSNRSDTFPSG	CELSR3	1176	Q9NYQ7
NFTQFIGSPNGTLYS	MEP1B	436	Q16820
YPNSGREGTAAQNFS	CSF2RA	111	P15509
SGFSQPENQNLLYSA	FANCD2	1076	Q9BXW9
NPAGLYSSENISNFN	PDLIM1	146	O00151
TGSNGLQRYTISSNP	PCDHB6	161	Q9Y5E3
LTYNNLSENSLPGNF	RSU1	116	Q15404
TDQYGNQIQAFSPSS	SMCHD1	1176	A6NHR9
REPNQAFGSGNNSYS	TARDBP	361	Q13148
SYTQGNPGTFRLQGQ	MARCOL	61	A0A1B0GUY1
DFRSPGSGLYSNLQQ	SIRT3	156	Q9NTG7
SGASNHQPNSNSGRY	IARS2	46	Q9NSE4
DGSPRTGQIFNQSYS	GH2	156	P01242
RDSGNSPGNAFYSNV	TMIGD2	181	Q96BF3
NLSSPGSYQRFGQSN	SLC36A1	31	Q7Z2H8
SSGNSSSGNYFTPQQ	SUPT20H	471	Q8NEM7
TGFTNIPSRYGTNNR	SLC30A6	441	Q6NXT4
NYGSPSRFQNENSGS	ZNF407	1191	Q9C0G0
STGSYSINFVQNPNN	TTC1	276	Q99614
NTPRGNYNESRGGQS	VIRMA	1731	Q69YN4